Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nantkwest Inc CS (NQ: NK )

32.49 USD UNCHANGED
Last Price Updated: 7:37 PM EST, Mar 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Nantkwest Inc CS

< Previous 1 2 3 4 5 6 7 8 9 Next >
ImmunityBio and NantKwest Complete Merger
ImmunityBio, Inc. and NantKwest, Inc. (NASDAQ: NK), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing... 
From Business Wire News Releases
Stockholders of NantKwest Approve Merger With ImmunityBio
NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the... 
From Business Wire News Releases
ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S.
ImmunityBio, Inc., a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced the first cohorts of their... 
From Business Wire News Releases
SHAREHOLDER ALERT: Barr Law Group Investigating NK, IQDNX, JELD, and MDXG; Shareholders are Encouraged to Contact the Firm
From GlobeNewswire News Releases
All Three Independent Proxy Advisory Firms – ISS, Glass Lewis and Egan-Jones – Recommend NantKwest Stockholders Vote “FOR” the Pending Merger With ImmunityBio
NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced that leading independent proxy advisory firms Institutional Shareholder Services Inc.... 
From Business Wire News Releases
ImmunityBio Appoints John Brennan and Wesley Clark to Board of Directors
ImmunityBio, Inc., a privately-held immunotherapy company, today announced the appointment of John Brennan, former Central Intelligence Agency Director, and Wesley Clark, retired U.S. Army General, to... 
From Business Wire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CTB, PBCT, HMSY, NK, SPWH
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Merger Investigation
From GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, CLGX, SYNC, NK; Shareholders Are Encouraged to Contact the Firm
From GlobeNewswire News Releases
ImmunityBio Announces ASCO Genitourinary Cancer Symposium Presentation of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invasive Bladder Cancer CIS with 71% Complete Response Rate
ImmunityBio, Inc., a privately-held immunotherapy company, today announced the oral presentation of “Phase II/III clinical results of IL-15RαFc superagonist N-803 with BCG in BCG-unresponsive... 
From Business Wire News Releases
Lifshitz Law Firm, P.C. Announces Investigation of CATM, FFG, NK, and VIE
From ACCESSWIRE
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, FFG, ALXN, NK, HLIX; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered... 
From PR Newswire
ImmunityBio and NantKwest Announce FDA Authorization to Study hAd5 T-Cell COVID-19 Vaccine for Combination of Subcutaneous, Oral and Sublingual Boost to Induce T-Cell, Mucosal, and Antibody Immunity
ImmunityBio, Inc., a privately-held immunotherapy company, and NantKwest, Inc. (NASDAQ: NK), a clinical-stage, natural killer cell-based therapeutics company, today announced they have received FDA... 
From Business Wire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates NK, ALXN, CATM, CGIX, MTSC; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
SHAREHOLDER ALERT: Barr Law Group Investigating NK, PS, JELD, and APLT; Shareholders are Encouraged to Contact the Firm
From GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRGX, RP, NK, CGIX; Shareholders Are Encouraged to Contact the Firm
From ACCESSWIRE
NANTKWEST INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NantKwest, Inc. - NK
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of NantKwest, Inc. (NasdaqGS: NK) with... 
From Business Wire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates VIE, SMTX, NK, OBLN; Shareholders Are Encouraged to Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds NK, XLNX, GXGX, and ACEV Shareholders About Its Ongoing Investigations
From PR Newswire
Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - NHLD, COHR, MTSC, NK, PNM
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: 
From PR Newswire
ImmunityBio Announces Positive Phase 2 Results Showing That Anktiva Restores the Activity of Checkpoint Inhibitors in Patients Who Have Relapsed Checkpoint Immunotherapy in Non-Small Cell Lung Cancer
ImmunityBio, Inc., a privately held immunotherapy company, today announced the presentation of encouraging data in non-small cell lung cancer (NSCLC) from the company’s ongoing Phase 2b study,... 
From Business Wire News Releases
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates NHLD, COHR, ALSK, NK; Shareholders Are Encouraged to Contact the Firm
From GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds PROS, IPHI, NK and XLNX Shareholders About Its Ongoing Investigations
From PR Newswire
MERGER INVESTIGATION: Halper Sadeh LLP Investigates RP, BPFH, ALSK, NK, ANH; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 
From PR Newswire
RM LAW Announces Investigation of NantKwest, Inc.
RM LAW, P.C. is investigating potential claims against the board of directors of NantKwest, Inc. ("NantKwest" or the "Company") (NASDAQ: NK) concerning possible breaches of fiduciary duty and other... 
From PR Newswire
INVESTIGATION ALERT: Nationally Ranked Shareholder Rights Law Firm Labaton Sucharow is Investigating NantKwest, Inc. (NASDAQ: NK) for Potential Securities Violations and Breach of Fiduciary Duty
Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential securities violations and breach of fiduciary duty against cellular therapies company... 
From Business Wire News Releases
NK INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of NantKwest, Inc.
From GlobeNewswire News Releases
ImmunityBio Simulations Reveal Why the New Strain of SARS-CoV-2 in South Africa is Spreading Fast and May ‘Escape’ Existing Immunity
ImmunityBio, Inc., a privately-held immunotherapy company, just reported their findings from a follow-up Molecular Dynamics (MD) simulation study of the SARS-CoV-2 spike receptor binding domain (RBD)... 
From Business Wire News Releases
ImmunityBio Announces Phase I Trial of COVID-19 Vaccine Candidate in South Africa as New Variants of SARS-CoV-2 Spread
ImmunityBio, Inc., a privately-held immunotherapy company, today announced it has received authorization from the South Africa Health Products Regulatory Authority (SAHPRA) to begin a Phase I clinical... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account